Optimizing Pregnancy Care with Patient Navigation for Moms on Opioid Surgery?
Official title: Randomized Trial: Optimizing Pregnancy and Treatment Interventions for Moms (OPTI-Mom) 3.0
Run by University of Utah · NCT07586917 · Data updated 2026-11-12
We’re testing whether patient navigation helps pregnant Medicaid members with opioid (and possibly stimulant) use disorders stay in care, use available medications, and connect with services better than usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 429 (estimated) |
| Sponsor | University of Utah Academic / other |
| Locations | 1 site (Salt Lake City, Utah) |
| Status | Recruiting |
| Started | July 10, 2026 |
| Main results expected | June 2029 |
| Study ends | June 2030 |
| Registry record updated | July 16, 2026 |
| Trial ID | NCT07586917 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults ≥18 years with opioid use disorder, at least 7 weeks pregnant, and either MOUD-naive or recently started, who can provide access to care records and has English proficiency.
✕Probably not a fit
Individuals unable to engage with telephone or video visits, or planning to move away before delivery, may see limited benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized study compares Patient Navigation to Usual Care for pregnant and postpartum individuals with opioid use disorder. Participants are assigned by chance to receive dedicated navigators who offer 14 sessions over up to 14 months and three surveys, all reachable by phone or video. The goal is to improve retention in care, medication use for opioid use disorder, and access to supportive services, addressing social and logistical barriers. MOUD is part of standard care, while there is no FDA-approved medication for stimulant use disorder, making integrated approaches particularly important. The trial is conducted at the University of Utah and targets English-speaking adults 18 and older who are ≥7 weeks pregnant and on MOUD or newly initiating MOUD.
Why it matters
Potential benefit: If successful, patients may stay engaged in care, continue MOUD, reduce substance use, and access coordinated services.
How similar studies have gone: Prior models integrating navigation and support have shown promise in improving engagement, though results vary by population and setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (≥18 years) * Opioid use disorder * ≥7 weeks gestation * Medication for opioid use disorder naive or newly initiated (≤6 weeks MOUD) * Provide permission to access administrative claims and medical records of their care and those of their neonate * Speak English Exclusion Criteria: * Plan to terminate pregnancy * Had a psychotic and/or manic episode in the last 30 days * Cannot provide contact information for themselves and 2 collateral contacts * Do not possess a reliable phone * Plan to move from the area ≤6 months of delivery * \>32 weeks gestation
Where it's running
-
University of Utah
Salt Lake City, Utah, United States Recruiting
Study contacts
- Study coordinator: Grace Sr. Clinical Research Coordinator
- Email: optimom@utah.edu
- Phone: 385-315-0698
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adaptive Decision Support for Addiction Treatment: Testing a Care Tool for ED Doctors to Help Buprenorphine Use
We’re testing a refined decision-support tool in emergency departments to help doctors prescribe buprenorphine to adults with moderate to severe opioid use disorder.
-
Helping rural jails use medications for opioid use disorder better
This project tests a training program to help jail staff in rural areas start or expand medications for opioid use disorder and see if it improves public health outcomes.
-
Family-based therapy for women in specialty courts with opioid use and sex-trade involvement
A pilot test will see if an adapted, family-focused therapy can be feasibly added to specialty-court programs for women who use opioids and have sex-trade involvement.
-
Women-focused overdose prevention during jail-to-community re-entry in Kentucky
This study tests an overdose prevention package for women leaving jail in rural Kentucky to see if it lowers overdose risk and improves treatment linkage.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.